Predictive M&A Intelligence for Institutional Decision-Makers.
Validated Signals
Total Value Analyzed
Pattern Match Rate
By the time you read about a deal in the Wall Street Journal, you are too late. Your competitors positioned six months ago, called the CEO before the banker did, and secured the advisory mandate while you were reading the press release.
What if you could see deals coming?
TESS analyzes four convergent signals that telegraph M&A activity six to twelve months early. When all four align simultaneously, a transaction follows within six months.
Real-time tracking of 12,900 PE-backed companies approaching exit windows.
Industry consolidation pressure across 100+ sectors with mathematical precision.
Policy changes creating scale-or-fail moments for entire industries.
$3.2T in dry powder mapped to sector deployment probabilities.
We validated TESS against 1,000 historical transactions across five years. Every signal pattern that preceded a deal in our dataset would have been visible six to twelve months in advance.
Pattern recognition, not hindsight.
Institutional-scale validation.
Signals aligned ahead of announcement.
Recent Example: Spring Health acquires Alma (January 29, 2026). TESS identified the signal in October 2025 (3 months early).
Know exactly when to exit portfolio companies for maximum returns.
Win advisory mandates by positioning six months before competitors.
Front-run announcements legally with event-driven strategies.
Identify acquisition targets before they are formally shopped.
"Timing one $2B exit perfectly = $200M-$500M in extra returns. TESS paid for itself in the first transaction." - PE Managing Director (Confidential)
$25,000 (3 months)
$250,000+ (12 months)
Custom Pricing
Limited to 50 institutional clients for data integrity.
Your competitors are already moving on deals you have not seen yet. TESS shows you what is coming.